Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | NAAA | Q02083 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.35 |
| ▸ | HRH1 | P35367 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | MLNR | O43193 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13278561 | 0.91 | CHRM3 (0.37) | EPHX1NAAACYP19A1CYP2C19CHRM3 | |
| SCHEMBL28784765 | 0.87 | NAAA (0.49) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL28107686 | 0.85 | NAAA (0.47) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL28107682 | 0.84 | EPHX1 (0.46) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL19690391 | 0.83 | EPHX1 (0.38) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL19690609 | 0.78 | NAAA (0.46) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL4200985 | 0.77 | NAAA (0.38) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL28305533 | 0.77 | CYP19A1 (0.43) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL29154403 | 0.76 | EPHX1 (0.40) | EPHX1NAAACYP19A1HTTCYP2C19 | |
| SCHEMBL14725806 | 0.75 | EPHX1 (0.50) | EPHX1NAAACYP19A1HTTCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4186931-A1 | POLYPROPYLENE RESIN COMPOSITION WITH HIGH FLOWABILITY AND ARTICLE MOLDED THEREFROM | Hanwha TotalEnergies Petrochemical Co., Ltd. (KR) | 2023-05-31 | — | — | EP | claimed |
| EP-4186931-A1 | POLYPROPYLENE RESIN COMPOSITION WITH HIGH FLOWABILITY AND ARTICLE MOLDED THEREFROM | Hanwha TotalEnergies Petrochemical Co., Ltd. (KR) | 2023-05-31 | — | — | EP | disclosed |
| WO-2023017805-A1 | POLYPROPYLENE COMPOSITION AND INJECTION-MOLDED ARTICLE | サンアロマー株式会社 | 2023-02-16 | — | — | WO | disclosed |
| US-11136421-B2 | Solid catalyst component for use in olefin polymerisation, catalyst, and application thereof | BEIJING LIHE TECHNOLOGY LTD (CN) | 2021-10-05 | — | — | US | disclosed |
| WO-2021015191-A1 | EXPANDABLE POLYPROPYLENE COMPOSITION AND INJECTION MOLDED FOAM | サンアロマー株式会社 | 2021-01-28 | — | — | WO | disclosed |
| US-20200071430-A1 | SOLID CATALYST COMPONENT FOR USE IN OLEFIN POLYMERISATION, CATALYST, AND APPLICATION THEREOF | BEIJING LIHE TECH LTD (CN) | 2020-03-05 | — | — | US | disclosed |
| US-20190169328-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | RENQIU LIHE TECH LTD (CN) | 2019-06-06 | — | — | US | disclosed |
| US-20170355792-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | RENQIU LIHE TECH LTD (CN) | 2017-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169328-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | COG2, GTF2I, POF1B | EPHX1 3610/4885NAAA 4455/4885CYP19A1 809/4885 |
| US-20170355792-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | COG2, COG7, COG4 | EPHX1 2500/4885NAAA 3757/4885CYP19A1 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.